Grasar Tablet is a combination analgesic formulation containing Aceclofenac 100mg, Paracetamol 325mg, and Serratiopeptidase 15mg, designed for the management of pain and inflammation associated with musculoskeletal disorders and postoperative conditions. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol provides analgesic and antipyretic effects through central inhibition of prostaglandin synthesis, complementing the anti-inflammatory action of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and tissue repair, enhancing the overall therapeutic efficacy. Grasar Tablet is indicated for conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries where pain relief and inflammation control are required. The combination offers rapid and sustained symptom relief with improved patient compliance. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risk factors. Adverse effects may include gastrointestinal discomfort, dizziness, or allergic reactions, and patients should report any unusual symptoms promptly.